FIELD: pharmaceutics.
SUBSTANCE: proposed group of inventions relates to the pharmaceutical industry, namely, to the use of a composition for the prevention and/or treatment of a disease caused by P. aeruginosa bacteria. The use of a CBD-based composition containing CBD in concentration from 1.9 mcg/ml to 200 mg/ml for the prevention and/or treatment of a disease caused by P. aeruginosa bacteria is proposed, where the disease or disorder is selected from a group consisting of nosocomial infection, respiratory tract infections, skin and soft tissue infections, wound infections, dental and buccal infections, otorhinolaryngological infections, urinary and/or prostate tract infections, gastrointestinal infections, biliary tract infections, eye infections, bacteremia, sepsis, central nervous system infections and endocarditis. A method for the prevention and/or treatment of a disease caused by P. aeruginosa bacteria is proposed, where the disease or disorder is selected from a group consisting of nosocomial infection, respiratory tract infections, skin and soft tissue infections, wound infections, dental and buccal infections, otorhinolaryngological infections, urinary and/or prostate tract infections, gastrointestinal infections, biliary tract infections, eye infections, bacteremia, sepsis, central nervous system infections and endocarditis, wherein the specified method includes the injection of therapeutically effective amount of the composition containing CBD in concentration from 1.9 mcg/ml to 200 mg/ml, to a subject who needs it.
EFFECT: above-described use and method are effective for inhibiting the formation of biofilm and/or virulence of P. aeruginosa, for the prevention and/or treatment of a disease caused by P. aeruginosa bacteria.
9 cl, 2 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION COMPRISING AN ANTIBIOTIC AND A DISPERSING AGENT OR AN ANTI-ADHESIVE AGENT | 2011 |
|
RU2739249C2 |
| PEPTIDES AND USE THEREOF | 2011 |
|
RU2590706C2 |
| COMPOSITION COMPRISING AN ANTIBIOTIC AND A DISPERSANT OR AN ANTI-ADHESIVE AGENT | 2011 |
|
RU2607660C2 |
| SOLID DISPERSION of 4- (3-ETHOXY-4-HYDROXIBENZIL) -5-OXO-5,6-DIHYDRO-4H- [1,3,4] -THIADIAZINE-2- (2,4-DIFLUOROPHENYL) -CARBOXAMIDE FOR PRODUCING PHARMACEUTICAL FORMULATION AND METHOD OF TREATMENT OF CHRONIC INFECTIOUS DISEASES | 2020 |
|
RU2743927C1 |
| USE OF POROUS MATERIALS FOR INHIBITING/DISTURBING THE SENSE OF QUORUM OF BACTERIA | 2017 |
|
RU2724550C2 |
| METHOD OF COUMARIN APPLICATION FOR INHIBITION OF DIFFERENT "QUORUM SENSING" LUX/LUXR TYPE SYSTEMS IN BACTERIA | 2019 |
|
RU2744456C1 |
| ANTIBACTERIAL COMPOSITION (EMBODIMENTS) AND USE OF PROTEIN AS ANTIMICROBIAL AGENT DIRECTED AGAINST BACTERIA PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI, SALMONELLA TYPHI AND STAPHYLOCOCCUS HAEMOLYTICUS (EMBODIMENTS) | 2019 |
|
RU2730613C1 |
| ANTIBACTERIAL COMPOSITION (EMBODIMENTS) AND USE OF PROTEIN AS ANTIMICROBIAL AGENT DIRECTED AGAINST GRAM-NEGATIVE BACTERIA: PSEUDOMONAS AERUGINOSA, ACINETOBACTER BAUMANNII, KLEBSIELLA PNEUMONIAE AND SALMONELLA TYPHI (EMBODIMENTS) | 2019 |
|
RU2730615C1 |
| INHIBITION OF BIOFILM ORGANISMS | 2010 |
|
RU2548786C2 |
| METHOD FOR SIMULATING BACTERIAL INFECTION WITH UNDERLYING BURN INJURY | 2013 |
|
RU2530564C1 |
